Kalinoski Thomas, DeWitt Cassandra, Belani Hrishikesh
Department of Internal Medicine, Olive View - UCLA Medical Center, 14445 Olive View Dr, Sylmar, CA, 91342, USA.
David Geffen School of Medicine at UCLA, 10833 Le Conte Ave, Los Angeles, CA, 90095, USA.
Arch Public Health. 2022 Apr 6;80(1):110. doi: 10.1186/s13690-022-00855-w.
Harm reduction is an accumulation of strategies aimed at preventing adverse health outcomes associated with illicit substance use. Several harm reduction programs and services exist within Los Angeles County (LAC), however their success relies in part on the application of harm reduction principles by local primary care providers serving patients with substance use disorders. This study aims to assess the readiness of patient-centered medical homes in the San Fernando Valley to provide effective harm reduction to patients who use injection drugs and identify barriers to doing so.
An online survey was distributed to primary care providers and social workers via email at federally qualified health centers and LAC Department of Health Services clinics in the San Fernando Valley between May and June 2019. It consisted of 22 multiple-choice, Likert scale, and short answer questions. The survey assessed knowledge of injection drug use (IDU), familiarity and utilization of harm-reduction and resources, and self-evaluation of attitudes and skills.
There were a total of 41 survey respondents across all clinics. Of respondents, 98% correctly identified heroin as a drug typically injected, and 93% identified Hepatitis C as an infectious risk of IDU. 63% of respondents use harm reduction strategies every few months or less. 34% prescribe buprenorphine routinely, and 76% prescribe pre-exposure prophylaxis to those at risk for Human Immunodeficiency Virus (HIV). 76% are comfortable discussing IDU with their patients, but 59% indicate that they lack the necessary skills, and 42% agree that they lack the time to address it.
Knowledge of IDU was adequate among those surveyed, although overall utilization of harm reduction was infrequent. There is a perceived deficit in skills and time to effectively provide harm reduction to primary care patients in the San Fernando Valley.
减少伤害是一系列旨在预防与非法药物使用相关的不良健康后果的策略。洛杉矶县(LAC)有多个减少伤害项目和服务,但它们的成功部分依赖于为患有物质使用障碍的患者提供服务的当地初级保健提供者对减少伤害原则的应用。本研究旨在评估圣费尔南多谷以患者为中心的医疗之家为注射吸毒患者提供有效减少伤害服务的准备情况,并确定这样做的障碍。
2019年5月至6月期间,通过电子邮件向圣费尔南多谷联邦合格健康中心和LAC卫生部诊所的初级保健提供者和社会工作者发放了一份在线调查问卷。该问卷由22个多项选择题、李克特量表题和简答题组成。该调查评估了对注射吸毒(IDU)的了解、对减少伤害及资源的熟悉程度和利用情况,以及对态度和技能的自我评估。
所有诊所共有41名受访者参与调查。在受访者中,98%正确识别出海洛因是一种通常注射使用的毒品,93%识别出丙型肝炎是注射吸毒的一种感染风险。63%的受访者每隔几个月或更少时间使用一次减少伤害策略。34%的受访者常规开具丁丙诺啡,76%的受访者为有感染人类免疫缺陷病毒(HIV)风险的人开具暴露前预防药物。76%的受访者愿意与患者讨论注射吸毒问题,但59%的受访者表示他们缺乏必要的技能,42%的受访者同意他们没有时间处理这个问题。
尽管减少伤害的总体利用率不高,但受访者对注射吸毒的了解较为充分。在圣费尔南多谷,人们认为在为初级保健患者有效提供减少伤害服务方面,技能和时间存在不足。